Suppr超能文献

用于改善胶体稳定性和体外生物相容性的壳聚糖纳米凝胶脂质涂层

Lipid Coating of Chitosan Nanogels for Improved Colloidal Stability and In Vitro Biocompatibility.

作者信息

Passos Gibson Victor, Nunes Julia Balestrero Braga, Falcao Deborah Quintanilha, Roullin V Gaëlle, Leblond Chain Jeanne

机构信息

Faculty of Pharmacy, Université de Montréal, Montréal, Québec, H3C 3J7, Canada.

Programa de Pós-Graduação em Ciências Aplicadas a Produtos para Saúde, Faculdade de Farmácia, Universidade Federal Fluminense, Rua Doutor Mário Viana 523, Santa Rosa, Niterói, 24241-000, Brazil.

出版信息

AAPS PharmSciTech. 2021 May 21;22(5):159. doi: 10.1208/s12249-021-02027-5.

Abstract

Chitosan-based carriers have coined their position as delivery agents. When assembled with polyanions into nanogels (NG), these vectors have enabled the delivery of drugs, genes, and proteins to a myriad of applications. However, the chemical and colloidal instability of chitosan nanoformulations in physiologically compatible media prejudices in vitro biocompatibility and, thus, scale-up applications. To overcome this issue, we envisaged the coating of chitosan nanogel with phospholipids. In this investigation, we report a two-stage synthesis of hybrid lipid-coated chitosan nanogels, named nanolipogels (NLG), to improve colloidal stability and in vitro biocompatibility over chitosan NG. Practically, we employed a mixing platform to first prepare chitosan NG by ionic gelation, dilute the suspension, and, in a second stage, coat the NG with lipids. We demonstrate that lipid coating increased particle size and reversed the ζ-potential to negative values, suggesting the successful formation of NLG, while maintaining a homogeneous size distribution (PDI < 0.25). Furthermore, multiple light scattering analysis confirmed NLG improved colloidal stability in phosphate buffer saline and cell culture medium, with respect to NG. Finally, lipid coating completely abrogated the cytotoxicity of NG when incubated at 50 μg·mL with HeLa, U87, or b.End3 cell lines and significantly improved the biocompatibility at 100 and 150 μg·mL. Future investigations will explore how the lipid coating affects drug loading, release profile, and the ability of NLG to deliver drugs and genes in vitro.

摘要

基于壳聚糖的载体已确立其作为递送剂的地位。当与聚阴离子组装成纳米凝胶(NG)时,这些载体已使药物、基因和蛋白质能够应用于众多领域。然而,壳聚糖纳米制剂在生理相容性介质中的化学和胶体不稳定性不利于其体外生物相容性,从而影响放大应用。为克服这一问题,我们设想用磷脂包覆壳聚糖纳米凝胶。在本研究中,我们报告了一种两阶段合成的混合脂质包覆壳聚糖纳米凝胶,称为纳米脂质凝胶(NLG),以提高其相对于壳聚糖NG的胶体稳定性和体外生物相容性。实际上,我们采用一个混合平台,首先通过离子凝胶化制备壳聚糖NG,稀释悬浮液,然后在第二阶段用脂质包覆NG。我们证明脂质包覆增加了粒径并使ζ电位变为负值,这表明成功形成了NLG,同时保持了均匀的粒径分布(PDI<0.25)。此外,多重光散射分析证实,相对于NG,NLG在磷酸盐缓冲盐水和细胞培养基中具有更好的胶体稳定性。最后,当与HeLa、U87或b.End3细胞系在50μg·mL下孵育时,脂质包覆完全消除了NG的细胞毒性,并在100和150μg·mL时显著提高了生物相容性。未来的研究将探索脂质包覆如何影响药物负载、释放曲线以及NLG在体外递送药物和基因的能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验